NCT01545245

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Cohort Study to Evaluate Effects of Prophylactic Treatment for Respiratory Syncytial (RS) Virus Infection in Respiratory Tract During Infancy on Subsequent Atopic Asthma in Preterm Infants

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 343 (actual)
• Sponsor: Tokai University · Academic / Other
• Sex: All
• Age: 3 Years – 3 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the study is to determine whether the incidence of atopic asthma after three years old may be suppressed in the children who were born as preterm infants and prophylactically treated with palivizumab for respiratory syncytial (RS) virus infections during the infancy. The secondary objective is to determine whether the incidence of recurrent wheezing after three years old may be suppressed in the children who were born as preterm infants and prophylactically treated with palivizumab for RS virus infections during the infancy.

Conditions

• Atopic Asthma
• Recurrent Wheezing

Timeline

• Start date: 2010-07-01
• Primary completion: 2014-01-01
• Completion: 2014-01-01
• First posted: 2012-03-06
• Last updated: 2014-12-08